Clinical effectiveness and cost-effectiveness of beta-interferon and glatiramer acetate for treating multiple sclerosis: systematic review and economic evaluation.

Beta-interferon and glatiramer acetate were effective for the treatment of multiple sclerosis, with cost-effectiveness ranging from £7000 to £34,000 per quality-adjusted life-year.

http://ift.tt/2xpWfMn